Ovid Therapeutics (OVID) Depreciation and Depletion (2016 - 2026)
Ovid Therapeutics' (OVID) quarterly Depreciation and Depletion came in at $35000.0 in Q1 2026, down 59.77% YoY from $87000.0 in Q1 2025, and little changed on a QoQ basis from $35000.0 in Q4 2025.
Ovid Therapeutics (OVID) Depreciation and Depletion (2016 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has 11 years of Depreciation and Depletion data on file, last reported at $35000.0 in Q1 2026.
- Quarterly Depreciation and Depletion fell 59.77% year-over-year to $35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148000.0 (down 61.66% YoY) and the FY2025 annual result came in at $200000.0, down 50.0% from the prior year.
- Depreciation and Depletion was little changed at $35000.0 in Q1 2026, from $35000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $131632.0 in Q4 2022 to a low of $17000.0 in Q3 2025.
- A 5-year average of $79598.4 and a median of $91000.0 in 2024 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2022 — Depreciation and Depletion surged 518.72% — and 2025, when it slumped 83.81%.
- Tracing OVID's Depreciation and Depletion over 5 years: stood at $131632.0 in 2022, then slumped by 37.71% to $82000.0 in 2023, then increased by 10.98% to $91000.0 in 2024, then slumped by 61.54% to $35000.0 in 2025, then changed by 0.0% to $35000.0 in 2026.
- The last three Depreciation and Depletion figures came in at $35000.0 (Q1 2026), $35000.0 (Q4 2025), and $17000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.10 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 38.91 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 3.18 Mn |
| 10 | Ovid Therapeutics | 385.37 Mn | 229.84 Mn | - | 35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,000.00 |
| Mar 31, 2026 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Jun 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 103,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Mar 31, 2024 | 101,000.00 |
| Dec 31, 2023 | 82,000.00 |
| Dec 31, 2023 | 82,000.00 |